Prevalence of Infection Among Type 2 Diabetes Mellitus
Overview
Authors
Affiliations
Background: Several conducted studies have reported a higher and more frequent infection rate in type 2 diabetes mellitus (T2DM). The aim of this study was to investigate the prevalence and its association between infection and T2DM.
Materials And Methods: A case and control study was conducted based on 529 T2DM patients and 529 control. was assessed by Serum anti- immunoglobulin G (IgG) and IgA. Furthermore, patients were investigated for fasting blood glucose (FBG) levels, glycosylated hemoglobin (HbA1c), serum cholesterol, and other biochemistry parameters.
Results: The findings showed a positive significantly higher antibody titer for infection (IgA > 250) in diabetic patients (50.7%) compared to controls (38.2%) ( < 0.001). Similarly, infection for IgG > 300 titer was higher in T2DM patients (73.5%) compared to controls 61.8%) ( < 0.001). Further, the mean values were statistically significant diabetes with infection for IgG > 300 titer and IgA > 250 titer, regarding Vitamin D, HbA1C ( < 0.001), FBG, calcium, creatinine, total cholesterol, LHDL, triglyceride levels, uric acid, bilirubin, thyroid-stimulating hormone (TSH), and systolic and diastolic blood pressure. The diabetic patients showed higher prevalence rate of symptoms than controls included: hypertension (14.3%), vomiting (15.5%), muscular symptoms (35.2%), bloating/distension (13.2%), abdominal pain (17%), nausea (9.6%), anemia (17%), kidneys (20.8%), chronic bronchitis (14.7%), gastrointestinal (23.8%), and diarrhea (20.4%).
Conclusions: The current study revealed that infections were significantly higher in diabetic patients compared to controls. Furthermore, T2DM patients infected with reported a higher prevalence rate of symptoms than .
Decreased Serum Insulin Receptor Messenger RNA Level in IgG Seropositive Type 2 Diabetic Patients.
Tagoe E, Appiah J, Boateng P, Quaye O, Bosomprah S Biomark Insights. 2024; 19:11772719241296619.
PMID: 39502307 PMC: 11536367. DOI: 10.1177/11772719241296619.
Li J, Yuan W, Liu J, Yang B, Xu X, Ren X BMC Endocr Disord. 2024; 24(1):168.
PMID: 39215298 PMC: 11363574. DOI: 10.1186/s12902-024-01694-2.
De la Torre K, Song M, Abe S, Rahman M, Islam M, Saito E J Diabetes. 2024; 16(6):e13561.
PMID: 38751364 PMC: 11096812. DOI: 10.1111/1753-0407.13561.
Chen H, Zhang G, Zhou X World J Diabetes. 2024; 15(2):170-185.
PMID: 38464370 PMC: 10921168. DOI: 10.4239/wjd.v15.i2.170.
Vitamin D and Its Association with Prevalence and Eradication: A Comprehensive Review.
Sasaran M, Marginean C, Lupu A, Koller A Nutrients. 2023; 15(16).
PMID: 37630738 PMC: 10459106. DOI: 10.3390/nu15163549.